Platelet-activating factor (PAF)-antagonists of natural origin

Fitoterapia

Volumn 84, Issue 1, 2013, Pages 180-201

  Singh, Preeti ^a   Singh, Ishwari Narayan ^b   Mondal, Sambhu Charan ^c   Singh, Lubhan ^c   Garg, Vipin Kumar ^c  

^a RVNI Dadri ^*  (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^c MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

In vitro tests; Natural products; Platelet activating factor (PAF); Platelet activating factor receptor (PAFR); Signaling pathway

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID PRECURSOR PROTEIN; ANDROGRAPHOLIDE; AURAPTENE; CINCHONINE; DICENTRINE; GINKGO BILOBA EXTRACT; GINKGOLIDE B; HONOKIOL; KADSURENONE; LEXIPAFANT; LIRIODENINE; MAGNOLOL; MANOALIDE; NATURAL PRODUCT; NEFERINE; PHOSPHOLIPASE A2 INHIBITOR; PIPERINE; PROSTAGLANDIN E2; PROTOPINE; QUERCITRIN; REACTIVE OXYGEN METABOLITE; RUPATADINE; SCALARADIAL; TETRANDRINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; YANGAMBIN;

ACUTE KIDNEY FAILURE; AGLAIA; ALLERGIC RHINITIS; ALPINIA OFFICINARUM; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ASTHMA; BLATTA ORIENTALIS; CHEMICAL STRUCTURE; CHROMOLAENA; CHRONIC URTICARIA; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; CORYDALIS; CYTOTOXICITY; DIABETES MELLITUS; DOPAMINE METABOLISM; ENZYME INHIBITION; GONIOTHALAMUS; HEADACHE; HERBAL MEDICINE; HISTAMINE RELEASE; HUMAN; IC 50; IN VITRO STUDY; INFLAMMATION; LEONURUS; LEUKOCYTE ACTIVATION; LIVER PROTECTION; MAGNOLIACEAE; MYALGIA; NEOPLASM; NEURALGIA; NEUROTOXICITY; NONHUMAN; OCOTEA; PANCREAS ISLET BETA CELL; PANCREATITIS; PHYLLANTHUS AMARUS; PIPER (PLANT); PIPER LONGUM; PRIORITY JOURNAL; RABDOSIA; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SYRINGA; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ANIMALS; BIOLOGICAL AGENTS; HUMANS; MOLECULAR STRUCTURE; PLANTS; PLATELET ACTIVATING FACTOR;

EID: 84873334390     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2012.11.002     Document Type: Review

References (235)

1. D.J. Hanahan, C.A. Demopoulos, J. Liehr, and R.N. Pinckard Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine J Biol Chem 255 12 1980 5514 5516
2. J.O. Shaw, R.N. Pinckard, K.S. Ferrigni, L.M. McManus, and D.J. Hanahan Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn- glycerol-3-phosphorylcholine (platelet activating factor) J Immunol 127 3 1981 1250 1255
3. H.P. Rang, M.M. Dale, J.M. Ritter, and R.J. Flower Rang and Dale's pharmacology - printed resource 2007 Churchill Livingstone Elsevier Edinburgh
4. L.M. McManus, D.J. Hanahan, and R.N. Pinckard Human platelet stimulation by acetyl glyceryl ether phosphorylcholine J Clin Invest 67 3 1981 903 906
5. K. Hattori, H. Adachi, A. Matsuzawa, K. Yamamoto, M. Tsujimoto, and J. Aoki cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II J Biol Chem 271 51 1996 33032 33038
6. G. Montrucchio, A. Sapino, B. Bussolati, G. Ghisolfi, S. Rizea-Savu, and L. Silvestro Potential angiogenic role of platelet-activating factor in human breast cancer Am J Pathol 153 5 1998 1589 1596
7. A.B. Tsoupras, C. Iatrou, C. Frangia, and C.A. Demopoulos The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants Infect Disord Drug Targets 9 4 2009 390 399
8. Z. Honda, S. Ishii, and T. Shimizu Platelet-activating factor receptor J Biochem 131 6 2002 773 779
9. J.C.S. Aliberti, F.S. Machado, R.T. Gazzinelli, M.M. Teixeira, and J.S. Silva Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice Infect Immun 67 6 1999 2810 2814
10. P.M. Henson Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils I. Characteristics of the secretory response J Exp Med 143 4 1976 937 952
11. C.M. Suquet, and R.W. Leid Aggregation of equine platelets by PAF (platelet-activating factor) Inflammation 7 2 1983 197 203
12. J. Chen, L. Yang, J.M. Foulks, A.S. Weyrich, G.K. Marathe, and T.M. Mcintyre Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis J Lipid Res 48 11 2007 2365 2376
13. K. Karasawa, X. Qiu, and T. Lee Purification and characterization from rat kidney membranes of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs, and C2-ceramide J Biol Chem 274 13 1999 8655 8661
14. S. Ishii, T. Nagase, F. Tashiro, K. Ikuta, S. Sato, and I. Waga Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor EMBO J 16 1 1997 133 142
15. S. Ishii, T. Kuwaki, T. Nagase, K. Maki, F. Tashiro, and S. Sunaga Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor J Exp Med 187 11 1998 1779 1788
16. P. Hilliquin, H. Houbaba, J. Aha, J. Benveniste, and C.J. Menkes Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis: influence of parenteral corticosteroids Scand J Rheumatol 24 3 1995 169 173
17. C.A. Demopoulos, H.C. Karantonis, and S. Antonopoulou Platelet activating factor - a molecular link between atherosclerosis theories Eur J Lipid Sci Technol 105 11 2003 705 716
18. W. Hsueh, F. Gonzalez-Crussi, and J.L. Arroyave Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia FASEB J 1 5 1987 403 405
19. B. Czarnetzki Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses Clin Exp Immunol 54 2 1983 486 492
20. A.J. Wardlaw, R. Moqbel, O. Cromwell, and A.B. Kay Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils J Clin Invest 78 6 1986 1701 1706
21. J.M. Cruzado, J. Torras, M. Riera, N. Lloberas, I. Herrero, and E. Condom Effect of a platelet activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model Clin Exp Immunol 113 1 1998 136 144
22. A.B. Tsoupras, E. Fragopoulou, T. Nomikos, C. Iatrou, S. Antonopoulou, and C.A. Demopoulos Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells Mediators Inflamm 2007 27683 27693
23. K.M. Maclennan, P.F. Smith, and C.L. Darlington Platelet-activating factor in the CNS Prog Neurobiol 50 5-6 1996 585 596
24. M. Triggiani, R.P. Schleimer, J.A. Warner, and F.H. Chilton Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells J Immunol 147 2 1991 660 666
25. F. Snyder Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators Am J Physiol Cell Physiol 259 5 1990 C697 C708
26. J.V. Bonventre, Z. Huang, M.R. Taheri, E. O'Leary, E. Li, and M.A. Moskowitz Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2 Nature 390 6660 1997 622 625
27. L.W. Tjoelker, C. Wilder, C. Eberhardt, D.M. Stafforini, G. Dietsch, and B. Schimpf Anti-inflammatory properties of a platelet-activating factor acetylhydrolase Nature 374 6522 1995 549 553
28. N.G. Bazan Inflammation. A signal terminator Nature 374 6522 1995 501 502
29. L.R. Liu, and S.H. Xia Role of platelet-activating factor in the pathogenesis of acute pancreatitis World J Gastroenterol 12 4 2006 539 545
30. F.P. Gómez, and R. Rodriguez-Roisin Platelet-activating factor antagonists: current status in asthma BioDrugs 14 1 2000 21 30
31. T. Brock Platelet-activating factor: activator of inflammation, angiogenesis, and metastasis Cyman Chem 2012
32. M. Kester, C.P. Thomas, J. Wang, and M.J. Dunn Platelet activating factor stimulates multiple signaling pathways in cultured rat mesangial cells J Cell Physiol 153 2 1992 244 255
33. B.A. Moharam, I. Jantan, J. Jalil, and K. Shaari Inhibitory effects of phylligenin and quebrachitol isolated from Mitrephora vulpina on platelet activating factor receptor binding and platelet aggregation Molecules 15 11 2010 7840 7848
34. K.C. Chung, and P.J. Barnes Platelet-activating factor: a potent mediator of inflammation Postgrad Med J 65 764 1989 420 421
35. S. Blankenberg, D. Stengel, H.J. Rupprecht, C. Bickel, J. Meyer, and F. Cambien Plasma PAF-acetylhydrolase in patients with coronary artery disease J Lipid Res 44 7 2003 1381 1386
36. S.M. Allan, and N.J. Rothwell Inflammation in central nervous system injury Philos Trans R Soc Lond B Biol Sci 358 1438 2003 1669 1677
37. J.L. Wallace, P. Braquet, G.C. Ibbotson, W.K. MacNaughton, and G. Cirino Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease J Lipid Mediat 1 1 1989 13 23
38. K. Nakagome, S. Matsushita, and M. Nagata Neutrophilic inflammation in severe asthma Int Arch Allergy Immunol 158 1 2012 96 102
39. 2 +-dependent manner Int J Cardiol 143 1 2010 86 93
40. D.M. Marotta, R. Costa, E.M. Motta, E.S. Fernandes, R. Medeiros, and N.L.M. Quinto Mechanisms underlying the nociceptive responses induced by platelet-activating factor (PAF) in the rat paw Biochem Pharmacol 77 7 2009 1223 1235
41. C. Shi, J. Liu, F. Wu, and D.T. Yew Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice Int J Mol Sci 11 1 2010 107 123
42. S.J. Konturek, A. Dembinski, P.J. Konturek, Z. Warzecha, J. Jaworek, and P. Gustaw Role of platelet activating factor in pathogenesis of acute pancreatitis in rats Gut 33 1992 1268 1274
43. R. Medzhitov Inflammation 2010: new adventures of an old flame Cell 140 6 2010 771 776
44. E.S. Lee, J. Jiang, G.C. Sund, W.T. Simonson, J. Graham, and G. Dietsch Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat Diabetes 48 1 1999 43 49
45. B. Ersoy, A. Huseyinov, and S. Darcan The role of platelet-activating factor in pathogenesis of type 1 diabetes Diabetes Care 28 4 2005 980
46. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 6801 2000 249 257
47. J.T. Wu, and J.G. Kral The NF-B/IkB signaling system: a molecular target in breast cancer therapy J Surgic Res 123 2005 158 169
48. J.M. Lopez-Novoa Potential role of platelet activating factor in acute renal failure Kidney Int 55 5 1999 1672 1682
49. A. Kasperska-Zajac, Z. Brzoza, and B. Rogala Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy Recent Pat Inflamm Allergy Drug Discov 2 1 2008 72 76
50. K.F. Chung, and P.J. Barnes Role for platelet-activating factor in asthma Lipids 26 12 1991 1277 1279
51. P.J. Barnes PAF, eosinophils and asthma J Lipid Mediat 5 2 1992 155 158
52. M. Hershkowitz, and A. Adunsky Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients Neurobiol Aging 17 6 1996 865 868
53. C. Bate, M. Salmona, and A. Williams Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β1-42 J Neuroinflammation 1 1 2004 10.1186/1742-2094-1-4
54. C. Bate, M. Salmona, and A. Williams The role of platelet activating factor in prion and amyloid-β neurotoxicity Neuroreport 15 3 2004 509 513
55. N.G. Bazan, V. Colangelo, and W.J. Lukiw Prostaglandins and other lipid mediators in Alzheimer's disease Prostaglandins Other Lipid Mediat 68 2002 197 210
56. K. Ley Molecular mechanisms of leukocyte recruitment in the inflammatory process Cardiovasc Res 32 4 1996 733 742
57. 4 dependent mechanism Free Radic Biol Med 22 6 1997 947 954
58. R.C. Garland, D. Sun, S. Zandi, F. Xie, S. Faez, and F. Tayyari Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury FASEB J 25 4 2011 1284 1294
59. M.G.M. Castor, B.M. Rezende, C.B. Resende, P.T.T. Bernardes, D. Cisalpino, and A.T. Vieira Platelet-activating factor receptor plays a role in the pathogenesis of graft-versus-host disease by regulating leukocyte recruitment, tissue injury, and lethality J Leukoc Biol 91 4 2012 629 639
60. A. Dulioust, P. Hilliquin, C.J. Menkes, J. Benveniste, and B. Arnoux Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases Scand J Rheumatol 21 4 1992 161 164
61. Y.S. Ho, L. Swenson, U. Derewenda, L. Serre, Y. Wei, and Z. Dauter Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer Nature 385 1997 89 93
62. K. Ogata, M. Bong Jin, M. Taniguchi, T. Suzuki, T. Shimamura, and N. Kitagawa Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with Ly3297221 Transplantation 71 8 2001 1040 1046
63. W. Sjursen, O.L. Brekke, and B. Johansen Original contributions-original articles-secretory and cytosolic phospholipase A2 regulate the long-term cytokine-induced eicosanoid production in human keratinocytes Cytokine 12 8 2000 1189 1194
64. S. Ishii, T. Nagase, and T. Shimizu Platelet-activating factor receptor Prostaglandins Other Lipid Mediat 68 2002 599 609
65. E.M. Williamson, D.T. Okpako, and F.J. Evans Selection, preparation, and pharmacological evaluation of plant material 1996 Wiley
66. E. Piers, and K.F. Cheng Stereoselective synthesis of α-bulnesene, 4-epi-α-bulnesene, and 5-epi-α-bulnesene Can J Chem 48 14 1970 2234 2245
67. N.X. Dung, P.A. Leclercq, T.H. Thain, and L.D. Moi Chemical composition of patchouli oil from Vietnam J Essent Oil Res 2 1989 99 100
68. Y.C. Tsai, H.C. Hsu, W.C. Yang, W.J. Tsai, C.C. Chen, and T. Watanabe α-Bulnesene, a PAF inhibitor isolated from the essential oil of Pogostemon cablin Fitoterapia 78 1 2007 7 11
69. H.C. Hsu, W.C. Yang, W.J. Tsai, C.C. Chen, H.Y. Huang, and Y.C. Tsai α-Bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin Biochem Biophys Res Commun 345 3 2006 1033 1038
70. T.C. Lu, J.C. Liao, T.H. Huang, Y.C. Lin, C.Y. Liu, and Y. Chiu Analgesic and anti-inflammatory activities of the methanol extract from Pogostemon cablin Evid Based Complement Altern Med 2011 10.1093/ecam/nep183
71. N. Mohd Nashriq Patchoili oil extraction using ultrasonic extraction method Universiti Malaysia Pahang 2008
72. H.W. Kim, S.J. Cho, B.Y. Kim, S.I. Cho, and Y.K. Kim Pogostemon cablin as ROS scavenger in oxidant-induced cell death of human neuroglioma cells Evid Based Complement Altern Med 7 2 2010 239 247
73. Y.C. Shen, C.F. Chen, and W.F. Chiou Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide Planta Med 66 4 2000 314 317
74. Y. Zhang, Y. Li, Q. Yang, X. Weng, Y. Dong, and X. Zhu Rat intestine absorption characteristics study on andrographolide with isolated everted intestine model Chin J Exp Tradit Med Formul 2009 [doi: CNKI:SUN:ZSFX.0.2010-09- 034]
75. W. Chatuphonprasert, K. Jarukamjorn, S. Kondo, and N. Nemoto Synergistic increases of metabolism and oxidation-reduction genes on their expression after combined treatment with a CYP1A inducer and andrographolide Chem Biol Interact 182 2 2009 233 238
76. A. Panossian, A. Hovhannisyan, G. Mamikonyan, H. Abrahamian, E. Hambardzumyan, and E. Gabrielian Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human Phytomedicine 7 5 2000 351 364
77. X. He, J. Li, H. Gao, F. Qiu, K. Hu, and X. Cui Identification of a rare sulfonic acid metabolite of andrographolide in rats Drug Metab Dispos 31 8 2003 983 985
78. S.K. Ojha, M. Nandave, S. Kumari, and D.S. Arya Antioxidant activity of Andrographis paniculata in ischemic myocardium of rats Glob J Pharmacol 3 3 2009 154 157
79. K. Jarukamjorn, and N. Nemoto Pharmacological aspects of Andrographis paniculata on health and its major diterpenoid constituent andrographolide J Health Sci 54 4 2008 370 381
80. A. Puri, R. Saxena, R.P. Saxena, K.C. Saxena, V. Srivastava, and J.S. Tandon Immunostimulant agents from Andrographis paniculata J Nat Prod 56 7 1993 995 999
81. M.I. Iruretagoyena, J.A. Tobar, P.A. Gonzalez, S.E. Sepulveda, C.A. Figueroa, and R.A. Burgos Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse J Pharmacol Exp Ther 312 1 2005 366 372
82. E. Amroyan, E. Gabrielian, A. Panossian, G. Wikman, and H. Wagner Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation Phytomedicine 6 1 1999 27 31
83. P. Thisoda, N. Rangkadilok, N. Pholphana, L. Worasuttayangkurn, S. Ruchirawat, and J. Satayavivad Inhibitory effect of Andrographis paniculata extract and its active diterpenoids on platelet aggregation Eur J Pharmacol 553 1-3 2006 39 45
84. W.J. Lu, J.J. Lee, D.S. Chou, T. Jayakumar, T.H. Fong, and G. Hsiao A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP J Mol Med 89 12 2011 1261 1273
85. M.A. Hidalgo, A. Romero, J. Figueroa, P. Cortes, I.I. Concha, and J.L. Hancke Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells Br J Pharmacol 144 5 2005 680 686
86. Z. Zhang, J. Jiang, P. Yu, X. Zeng, J.W. Larrick, and Y. Wang Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment J Transl Med 7 2009 10.1186/1479-5876-7-62
87. W.W. Chao, Y.H. Kuo, and B.F. Lin Anti-inflammatory activity of new compounds from Andrographis paniculata by NF-kappaB transactivation inhibition J Agric Food Chem 58 4 2010 2505 2512
88. M.A. Akbarsha, and P. Murugaian Aspects of the male reproductive toxicity/male antifertility property of andrographolide in albino rats: effect on the testis and the cauda epididymidal spermatozoa Phytother Res 14 6 2000 432 435
89. S.S. Handa, and A. Sharma Hepatoprotective activity of andrographolide from Andrographis paniculata against carbontetrachloride Indian J Med Res 92 1990 276 283
90. M.B. Patel, V.M. Kadakia, and S.H. Mishra Simultaneous estimation of andrographolide and wedelolactone in herbal formulations Indian J Pharm Sci 70 5 2008 689 693
91. H.W. Wang, H.Y. Zhao, and S.Q. Xiang Effects of Andrographis paniculata component on nitric oxide, endothelin and lipid peroxidation in experimental atherosclerotic rabbits Zhongguo Zhong Xi Yi Jie He Za Zhi 17 9 1997 547 549
92. R. Subramanian, M.Z. Asmawi, and A. Sadikun In vitro alpha-glucosidase and alpha-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide Acta Biochim Pol 55 2 2008 391 398
93. D.H. Kuo, Y.S. Lai, C.Y. Lo, A.C. Cheng, H. Wu, and M.H. Pan Inhibitory effect of magnolol on TPA-induced skin inflammation and tumor promotion in mice J Agric Food Chem 58 9 2010 5777 5783
94. M.K. Pyo, Y.Y. Lee, and H.S. Yun-Choi Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata Arch Pharm Res 25 3 2002 325 328
95. F.H. Epstein, P.J. Barnes, and M. Karin Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 15 1997 1066 1071
96. R. Raghavan, S. Cheriyamundath, and J. Madassery Andrographolide, a new potential NF-κB inhibitor: docking simulation and evaluation of drug-likeness Mol Simul 38 7 2012 582 588
97. H.O. Yang, D.Y. Suh, and B.H. Han Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis Planta Med 61 1 1995 37 40
98. I. Jantan, I.A.A. Rafi, and J. Jalil Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants Phytomedicine 12 1-2 2005 88 92
99. I. Jantan, M.M. Pisar, M.S. Idris, M. Taher, and R.M. Ali In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding Planta Med 68 12 2002 1133 1134
100. K. Umeno, E. Hori, M. Tsubota, H. Shojaku, T. Miwa, and Y. Nagashima Effects of direct Cedrol inhalation into the lower airway on autonomic nervous activity in totally laryngectomized subjects Br J Clin Pharmacol 65 2 2008 188 196
101. E. Hori, H. Shojaku, N. Watanabe, Y. Kawasaki, M. Suzuki, and M.F.P. de Araujo Effects of direct cedrol inhalation into the lower airway on brain hemodynamics in totally laryngectomized subjects Auton Neurosci 168 1-2 2012 88 92
102. M.H. Jin, S.G. Park, Y.L. Hwang, M.H. Lee, N.J. Jeong, and S.S. Roh Cedrol enhances extracellular matrix production in dermal fibroblasts in a MAPK-dependent manner Ann Dermatol 24 1 2012 16 21
103. D. Kagawa, H. Jokura, R. Ochiai, I. Tokimitsu, and H. Tsubone The sedative effects and mechanism of action of cedrol inhalation with behavioral pharmacological evaluation Planta Med 69 7 2003 637 641
104. T. Akutsu, S. Tanaka, Y. Murakami, K. Nakajima, Y. Nagashima, and Y. Yada Effect of the natural fragrance "œcedrol"• on dopamine metabolism in the lateral hypothalamic area of restrained rats: a microdialysis study Psychol Med 1287 2006 195 200 [Conference Proceeding]
105. P. Genne, O. Duchamp, E. Solary, J. Magnette, J.P. Belon, and B. Chauffert Cinchonine per os: efficient circumvention of P-glycoprotein-mediated multidrug resistance Anticancer Drug Des 10 2 1995 103 108
106. Z. Gong, Z. Zhang, and X. Yang Optosensor for cinchona alkaloids with C18 silica gel as a substrate Analyst 122 3 1997 283 285
107. B.H. Shah, Z. Nawaz, S.S. Virani, I.Q. Ali, S.A. Saeed, and A.H. Gilani The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx Biochem Pharmacol 56 8 1998 955 960
108. T.A. van Beek Ginkgolides and bilobalide: their physical, chromatographic and spectroscopic properties Bioorg Med Chem 13 17 2005 5001 5012
109. S.S. Chatterjee, E.L. Kondratskaya, and O.A. Krishtal Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators Pharmacopsychiatry 36 1 2003 S68 S77
110. A.J. Thompson, G.E. Jarvis, R.K. Duke, G.A.R. Johnston, and S.C.R. Lummis Ginkgolide B and bilobalide block the pore of the 5-HT3 receptor at a location that overlaps the picrotoxin binding site Neuropharmacology 60 2-3 2011 488 495
111. H. Kimura, N.Z. Wu, R. Dodge, D.P. Spencer, B.M. Klitzman, and T.M. McIntyre Inhibition of radiation-induced up-regulation of leukocyte adhesion to endothelial cells with the platelet-activating factor inhibitor, BN52021 Int J Radiat Oncol Biol Phys 33 3 1995 627 633
112. V. Papadopoulos, A. Kapsis, H. Li, H. Amri, M. Hardwick, and M. Culty Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells Anticancer Res 20 5A 2000 2835 2847
113. W. Zhu, G. Chen, L. Hu, X. Luo, C. Gui, and C. Luo QSAR analyses on ginkgolides and their analogues using CoMFA, CoMSIA, and HQSAR Bioorg Med Chem 13 2 2005 313 322
114. F.F. Mahmoud, D.D. Haines, H.T. Abul, A.T. Abal, B.O. Onadeko, and J.A. Wise In vitro effects of astaxanthin combined with ginkgolide B on T lymphocyte activation in peripheral blood mononuclear cells from asthmatic subjects J Pharmacol Sci 94 2 2004 129 136
115. A. Dabrowski, A. Gabryelewicz, and L. Chyczewski The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals Int J Pancreatol 8 1 1991 1 11
116. D. Sandoval, A. Gukovskaya, P. Reavey, S. Gukovsky, A. Sisk, and P. Braquet The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis Gastroenterology 111 4 1996 1081 1091
117. L. Hu, Z. Chen, X. Cheng, and Y. Xie Chemistry of ginkgolides: structure-activity relationship as PAF antagonists Pure Appl Chem 71 1999 1153 1156
118. W.C. LaFrance, E.C. Lauterbach, C.E. Coffey, S.P. Salloway, D.I. Kaufer, and A. Reeve The use of herbal alternative medicines in neuropsychiatry. A report of the ANPA committee on research J Neuropsychiatry Clin Neurosci 12 2 2000 177 192
119. P. Schiapparelli, G. Allais, I. Castagnoli Gabellari, S. Rolando, M.G. Terzi, and C. Benedetto Non-pharmacological approach to migraine prophylaxis: part II Neurol Sci 31 2010 137 139
120. M. Esposito, M. Ruberto, A. Pascotto, and M. Carotenuto Nutraceutical preparations in childhood migraine prophylaxis: effects on headache outcomes including disability and behaviour Neurol Sci 2012 1 4
121. H. Oberpichler, D. Sauer, C. RoBberg, H.D. Mennel, and J. Krieglstein PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus J Cereb Blood Flow Metab 10 1 1990 133 135
122. A.D. Grypioti, G. Kostopanagiotou, C.A. Demopoulos, A. Roussos, and M. Mykoniatis Platelet activating factor (PAF) antagonism with ginkgolide B protects the liver against acute injury. Importance of controlling the receptor of PAF Dig Dis Sci 53 4 2008 1054 1062
123. C. Shi, L. Zhao, B. Zhu, Q. Li, D.T. Yew, Z. Yao, Q. Li, D.T. Yew, and Z. Yao Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against β-amyloid peptide-induced toxicity in SH-SY5Y cells Chem Biol Interact 181 1 2009 115 123
124. Y. Li, and Y. Wang Evaluation of tussilagone: a cardiovascular- respiratory stimulant isolated from Chinese herbal medicine Gen Pharmacol 19 2 1988 261 263
125. M.J. Cupp Toxicology and clinical pharmacology of herbal products 2000 Humana Pr Inc.
126. S.B. Hwang, M.N. Chang, M.L. Garcia, Q.Q. Han, L. Huang, and V.F. King L-652,469-a dual receptor antagonist of platelet activating factor and dihydropyridines from Tussilago farfara L. Eur J Pharmacol 141 2 1987 269 281
127. H.J. Lim, H.S. Lee, and J.H. Ryu Suppression of inducible nitric oxide synthase and cyclooxygenase-2 expression by tussilagone from farfarae flos in BV-2 microglial cells Arch Pharm Res 31 5 2008 645 652
128. R. Yamazaki, J. Sugatani, I. Fujii, M. Kuroyanagi, K. Umehara, and A. Ueno Development of a novel method for determination of acetyl-CoA:1-alkyl-sn- glycero-3-phosphocholine acetyltransferase activity and its application to screening for acetyltransferase inhibitors. Inhibition by magnolol and honokiol from Magnoliae cortex Biochem Pharmacol 47 6 1994 995 1006
129. T.H. Tsai, C.J. Chou, and C.F. Chen Disposition of magnolol after intravenous bolus and infusion in rabbits Drug Metab Dispos 22 4 1994 518 521
130. T.H. Tsai, C.J. Chou, and C.F. Chen Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection J Pharm Pharmacol 48 1 1996 57 59
131. Z. Cheng Comparative studies on the interactions of honokiol and magnolol with human serum albumin J Pharm Biomed Anal 66 2012 240 251
132. A. Wu, B. Zeng, M. Huang, S. Li, J. Chen, and X. Lai The absorption and transport of magnolol in Caco-2 cell model Chin J Integr Med 2012 1 6
133. C.M. Teng, C.C. Chen, F.N. Ko, L.G. Lee, T.F. Huang, and Y.P. Chen Two antiplatelet agents from Mangolia officinalis Thromb Res 50 6 1988 757 765
134. K.S. Ahn, G. Sethi, S. Shishodia, B. Sung, J.L. Arbiser, and B.B. Aggarwal Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway Mol Cancer Res 4 9 2006 621 633
135. Y.M. Lee, G. Hsiao, H.R. Chen, Y.C. Chen, J.R. Sheu, and M.H. Yen Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats Eur J Pharmacol 422 1-3 2001 159 167
136. H.C. Ou, F.P. Chou, W.H. Sheu, S.L. Hsu, and W.J. Lee Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells Arch Toxicol 81 6 2007 421 432
137. Y.H. Chen, F.Y. Lin, P.L. Liu, Y.T. Huang, J.H. Chiu, and Y.C. Chang Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats Arch Pharm Res 32 2 2009 221 228
138. A. Muroyama, A. Fujita, C. Lv, S. Kobayashi, Y. Fukuyama, and Y. Mitsumoto Magnolol protects against MPTP/MPP +-induced toxicity via inhibition of oxidative stress in in vivo and in vitro models of Parkinson's disease Park Dis 2012 10.1155/2012/985157
139. H.Y. Chen, Y.C. Hung, E.J. Lee, T.Y. Chen, I.C. Chuang, and T.S. Wu The protective efficacy of magnolol in hind limb ischemia-reperfusion injury Phytomedicine 16 10 2009 976 981
140. C.C. Loong, J.H. Chiu, R.C. Tiao, Y.Y. Chiu, C.W. Wu, and W.Y. Lui Pretreatment with magnolol attenuates ischemia-reperfusion injury in rat small intestine Transplant Proc 33 7-8 2001 3737 3738
141. E.J. Park, Y.Z. Zhao, M. Na, K. Bae, Y.H. Kim, and B.H. Lee Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide-or d-galactosamine-induced toxicity in rat primary hepatocytes Planta Med 69 1 2003 33 37
142. A.M. Clark, F.S. El-Feraly, and W.S. Li Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J Pharm Sci 70 8 1981 951 952
143. K.Y. Ho, C.C. Tsai, C.P. Chen, J.S. Huang, and C.C. Lin Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis Phytother Res 15 2 2001 139 141
144. C.H. Ko, H.H. Chen, Y.R. Lin, and M.H. Chan Inhibition of smooth muscle contraction by magnolol and honokiol in porcine trachea Planta Med 69 6 2003 532 536
145. S.S. Chan, M. Zhao, L. Lao, H.H. Fong, and C.T. Che Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum Planta Med 74 4 2008 381 384
146. Y.R. Lin, H.H. Chen, C.H. Ko, and M.H. Chan Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures Neuropharmacology 49 4 2005 542 550
147. Y.R. Lin, H.H. Chen, C.H. Ko, and M.H. Chan Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage Eur J Pharmacol 537 1-3 2006 64 69
148. Y.R. Lin, H.H. Chen, Y.C. Lin, C.H. Ko, and M.H. Chan Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain J Biomed Sci 16 2009 10.1186/1423-0127-16-94
149. Y.H. Chen, S.J. Lin, J.W. Chen, H.H. Ku, and Y.L. Chen Magnolol attenuates VCAM-1 expression in vitro in TNF-α-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits Br J Pharmacol 135 1 2002 37 47
150. J.I.H.P. Wang, T.F.E.N. Ho, L.C.H.U. Chang, and C.C. Chen Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice J Pharm Pharmacol 47 10 1995 857 860
151. P. Ettinger-Epstein, D.M. Tapiolas, C.A. Motti, A.D. Wright, C.N. Battershill, and R. De Nys Production of manoalide and its analogues by the sponge Luffariella variabilis is hardwired Mar Biotechnol 10 1 2008 64 74
152. A. Soriente, M.M. De Rosa, A. Scettri, G. Sodano, M.C. Terencio, and M. Paya Manoalide Curr Med Chem 6 5 1999 415 431
153. 2 inactivation Mol Pharmacol 36 5 1989 782 788
154. A. Pommier, and P.J. Kocienski Synthesis of manoalide using a 1, 2-metallate rearrangement Chem Commun 12 1997 1139 1140
155. M. De Rosa, S. Giordano, A. Scettri, G. Sodano, A. Soriente, and P.G. Pastor Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues J Med Chem 41 17 1998 3232 3238
156. D.J. Schrier, C.M. Flory, M. Finkel, S.L. Kuchera, M.E. Lesch, and P.B. Jacobson The effects of the phospholipase A2 inhibitor, manoalide, on cartilage degradation, stromelysin expression, and synovial fluid cell count induced by intraarticular injection of human recombinant interleukin-1 alpha in the rabbit Arthritis Rheum 39 8 1996 1292 1299
157. S.J. Piao, H.J. Zhang, H.Y. Lu, F. Yang, W.H. Jiao, and Y.H. Yi Hippolides A-H, acyclic manoalide derivatives from the marine sponge Hippospongia lachne J Nat Prod 74 5 2011 1248 1254
158. K.A. Salam, A. Furuta, N. Noda, S. Tsuneda, Y. Sekiguchi, and A. Yamashita Inhibition of hepatitis C virus NS3 helicase by manoalide J Nat Prod 75 4 2012 650 654
159. L.P. Ponomarenko, A.I. Kalinovsky, and V.A. Stonik New scalarane-based sesterterpenes from the sponge Phyllospongia madagascarensis J Nat Prod 67 9 2004 1507 1510
160. K.B. Glaser, and Y.W. Lock Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production Biochem Pharmacol 50 7 1995 913 922
161. M.S. Barnette, J. Rush, L.A. Marshall, J.J. Foley, D.B. Schmidt, and H.M. Sarau Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function Biochem Pharmacol 47 9 1994 1661 1667
162. Y. Xie, L. Liu, X. Huang, Y. Guo, and L. Lou Scalaradial inhibition of epidermal growth factor receptor-mediated Akt phosphorylation is independent of secretory phospholipase A2 J Pharmacol Exp Ther 314 3 2005 1210 1217
163. R.C. Marques, S.R. de Medeiros, S. Dias Cda, J.M. Barbosa-Filho, and L.F. Agnez-Lima Evaluation of the mutagenic potential of yangambin and of the hydroalcoholic extract of Ocotea duckei by the Ames test Mutat Res 536 1-2 2003 117 120
164. F.C. de Sousa, B.A. Pereira, V.T. Lima, C.D. Lacerda, C.T. Melo, and J.M. Barbosa-Filho Central nervous system activity of yangambin from Ocotea duckei Vattimo (Lauraceae) in mice Phytother Res 19 4 2005 282 286
165. H. Wagner, R. Bauer, D. Melchart, P. Xiao, and A. Staudinger Chromatographic fingerprint analysis of herbal medicines: thin-layer and high performance liquid chromatography of Chinese drugs 2011 Springer
166. E. Tibirica Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants Cardiovasc Drug Rev 19 4 2001 313 328
167. H.C. Castro-Faria-Neto, P.T. Bozza, H.N. Cruz, C.L. Silva, F.A. Violante, and J.M. Barbosa-Filho Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies Planta Med 61 2 1995 101 105
168. J.M. Herbert, H.C. Castro-Faria-Neto, J.M. Barbosa-Filho, R.S. Cordeiro, and E. Tibirica Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes; studies with yangambin J Lipid Mediat Cell Signal 17 1 1997 1 14
169. C.M.Q. Jesus-Morais, E.F. Assis, R.S.B. Cordeiro, J.M. Barbosa-Filho, W.T. Lima, and ZL. Silva Yangambin, a lignan obtained from Ocotea duckei, differentiates putative PAF receptor subtypes in the gastrointestinal tract of rats Planta Med 66 3 2000 211 216
170. B.A. Moharam, I. Jantan, F. Ahmad, and J. Jalil Antiplatelet aggregation and platelet activating factor (PAF) receptor antagonistic activities of the essential oils of five Goniothalamus species Molecules 15 8 2010 5124 5138
171. F.J. Marcal, D.A. Cortez, T. Ueda-Nakamura, C.V. Nakamura, and B.P. Dias Filho Activity of the extracts and neolignans from Piper regnellii against methicillin-resistant Staphylococcus aureus (MRSA) Molecules 15 4 2010 2060 2069
172. T.Y. Shen, S.B. Hwang, M.N. Chang, T.W. Doebber, M.H. Lam, and M.S. Wu Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects Proc Natl Acad Sci U S A 82 3 1985 672
173. M.N. Chang, G.Q. Han, B.H. Arison, J.P. Springer, S.B. Hwang, and T. Ying Shen Neolignans from Piper futokadsura Phytochemistry 24 9 1985 2079 2082
174. C.Y. Li, W.J. Tsai, A.G. Damu, E.J. Lee, T.S. Wu, and N.X. Dung Isolation and identification of antiplatelet aggregatory principles from the leaves of Piper lolot J Agric Food Chem 55 23 2007 9436 9442
175. B.S. Park, D.J. Son, Y.H. Park, T.W. Kim, and S.E. Lee Antiplatelet effects of acidamides isolated from the fruits of Piper longum L Phytomedicine 14 12 2007 853 855
176. S.X. Zhang, K. Chen, X.J. Liu, D.C. Zhang, T.W. Tao-Wiedmann, and S. Leu The isolation and structural elucidation of three new neolignans, puberulins A, B, and C, as platelet activating factor receptor antagonists for Piper puberulum J Nat Prod 58 4 1995 540 547
177. I.S. Chen, Y.C. Chen, and C.H. Liao Amides with anti-platelet aggregation activity from Piper taiwanense Fitoterapia 78 6 2007 414 419
178. C.A. Kassuya, D.F. Leite, L.V. de Melo, V.L. Rehder, and J.B. Calixto Anti-inflammatory properties of extracts, fractions and lignans isolated from Phyllanthus amarus Planta Med 71 8 2005 721 726
179. C.A.L. Kassuya, A. Silvestre, and O. Menezes-de-Lima Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus: evidence for interaction with platelet activating factor receptor Eur J Pharmacol 546 1-3 2006 182 188
180. G. Fan, S. Kim, B.H. Han, and Y.N. Han Glyceroglycolipids, a novel class of platelet-activating factor antagonists from Kalimeris indica Phytochem Lett 1 4 2008 207 210
181. S.K. Ling, M. Pisar, and S. Man Platelet-activating factor (PAF) receptor binding antagonist activity of the methanol extracts and isolated flavonoids from Chromolaena odorata (L.) King and Robinson Biol Pharm Bull 30 6 2007 1150 1152
182. C. Nasopoulou, H.C. Karantonis, M. Andriotis, C.A. Demopoulos, and I. Zabetakis Antibacterial and anti-PAF activity of lipid extracts from sea bass (Dicentrarchus labrax) and gilthead sea bream (Sparus aurata) Food Chem 111 2 2008 433 438
183. N. Nordin, J. Jalil, I. Jantan, and S. Murad Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum Pharm Biol 50 3 2012 284 290
184. F.N. Ko, T.S. Wu, M.J. Liou, T.F. Huang, and C.M. Teng PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr Eur J Pharmacol 218 1 1992 129 135
185. I. Jantan, M. Pisar, H.M. Sirat, N. Basar, S. Jamil, and R.M. Ali Inhibitory effects of compounds from Zingiberaceae species on platelet activating factor receptor binding Phytother Res 18 12 2004 1005 1007
186. C.W. Phang, S.N.A. Malek, H. Ibrahim, and N.A. Wahab Antioxidant properties of crude and fractionated extracts of Alpinia mutica rhizomes and their total phenolic content Afr J Pharm Pharmacol 5 7 2011 842 852
187. C.M. Teng, H.L. Li, T.S. Wu, S.C. Huang, and T.F. Huang Antiplatelet actions of some coumarin compounds isolated from plant sources Thromb Res 66 5 1992 549 557
188. C.H.U.I. Liao, F.N. Ko, T.S. Wu, and C.H.E.M. Teng Bakkenolide G, a natural PAF• receptor antagonist J Pharm Pharmacol 49 12 1997 1248 1253
189. E.D. Coy, L.E. Cuca, and M. Sefkow Macrophyllin-type bicyclo [3.2. 1] octanoid neolignans from the leaves of Pleurothyrium cinereum J Nat Prod 72 7 2009 1245 1248
190. 2 + signaling Biochem Pharmacol 58 7 1999 1167 1172
191. J.M. Ringman, S.A. Frautschy, G.M. Cole, D.L. Masterman, and J.L. Cummings A potential role of the curry spice curcumin in Alzheimer's disease Curr Alzheimer Res 2 2 2005 131 136
192. C.V. Rao Regulation of COX and LOX by curcumin Adv Exp Med Biol 595 2007 213 226
193. C.M. Teng, S.M. Yu, C.C. Chen, Y.L. Huang, and T.F. Huang Inhibition of thrombin-and collagen-induced phosphoinositides breakdown in rabbit platelets by a PAF antagonist-denudatin B, an isomer of kadsurenone Thromb Res 59 1 1990 121 130
194. Y. Sheu-Meei, C. Chien-Chih, K. Feng-Nien, H. Yu-Lin, H. Tur-Fu, and T. Che-Ming Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets Biochem Pharmacol 43 2 1992 323 329
195. B. Zhang, and K. Long Effects of glaucocalyxin A on aggregation and cAMP levels of rabbit platelets in vitro Zhongguo Yao Li Xue Bao 14 4 1993 347 350
196. C. Touvay, B. Vilain, P. Sirois, M. Soufir, and P. Braquet Gossypol: a potent inhibitor of PAF-acether-•and leukotriene-induced contractions of guinea-pig lung parenchyma strips J Pharm Pharmacol 39 6 1987 454 458
197. Y. Enomoto, K. Shiomi, M. Hayashi, R. Masuma, T. Kawakubo, and K. Tomosawa Herquline B, a new platelet aggregation inhibitor produced by Penicillium herquei Fg-372 J Antibiot 49 1 1996 50 53
198. Y.G. Chen, G.W. Qin, Y.Y. Xie, K.F. Cheng, Z.W. Lin, and H.D. Sun Lignans from Kadsura angustifolia J Asian Nat Prod Res 1 2 1998 125 131
199. Q. Xu, Q. Li, Y. Liu, Y. Feng, S. Yang, and X. Li New lignans from Syringa reticulata var. mandshurica Chem Nat Comp 46 3 2010 366 369
200. C.H.U.I. Liao, F.N. Ko, C.L.I. Wu, and C.H.E.M. Teng Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets J Pharm Pharmacol 52 3 2000 353 359
201. J. Yu, and W.S. Hu Effects of neferine on platelet aggregation in rabbits Acta Pharmacol Sin 32 1 1997 1 4
202. M. Sugano, A. Sato, Y. Iijima, T. Oshima, K. Furuya, and H. Kuwano Phomactin A; a novel PAF antagonist from a marine fungus Phoma sp. J Am Chem Soc 113 14 1991 5463 5464
203. M. Sugano, A. Sato, Y. Iijima, K. Furuya, H. Kuwano, and T. Hata Phomactin E, F, and G: new phomactin-group PAF antagonists from a marine fungus Phoma sp. J Antibiot 48 10 1995 1188 1190
204. B.A. Moharam, I. Jantan, J. Jalil, and K. Shaari Inhibitory effects of phylligenin and quebrachitol isolated from Mitrephora vulpina on platelet activating factor receptor binding and platelet aggregation Molecules 15 11 2012 7840 7848
205. 2 production and platelet activating factor receptor binding Molecules 17 5 2012 4824 4835
206. C.M. Lee, L.M. Jiang, H.S. Shang, P.M. Hon, Y. He, and H.N. Wong Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus Br J Pharmacol 103 3 1991 1719 1724
207. H.O. Yang, D.Y. Suh, and B.H. Han Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis Planta Med 61 1 1995 37 40
208. F.N. Ko, T.S. Wu, S.T. Lu, Y.C. Wu, T.F. Huang, and C.M. Teng Antiplatelet effects of protopine isolated from tubers Thromb Res 56 2 1989 289 298
209. S.A. Saeed, R.U. Simjee, F. Mahmood, and N. Sultana Atta-ur-Rahman. Rhazimine from Rhazya stricta: a dual inhibitor of arachidonic acid metabolism and platelet activating factor-induced platelet aggregation Planta Med 59 1993 566 568
210. I. Jantan, M.M. Pisar, M.S. Idris, M. Taher, and R.M. Aii In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding Planta Med 68 12 2002 1133 1134
211. D.G. Li, Z.R. Wang, and H.M. Lu Pharmacology of tetrandrine and its therapeutic use in digestive diseases World J Gastroenterol 7 5 2001 627 629
212. 2 formation J Ethnopharmacol 66 2 1999 241 246
213. M.P. Mazura, D. Susanti, and M.A. Rasadah Anti-inflammatory action of components from Melastoma malabathricum Pharm Biol 45 5 2007 372 375
214. E.D. Coy-Barrera, L.E. Cuca-Suairez, and M. Sefkow PAF-antagonistic bicyclo [3.2. 1] octanoid neolignans from leaves of Ocotea macrophylla Kunth. (Lauraceae) Phytochemistry 70 10 2009 1309 1314
215. F.R. Chang, J.L. Wei, C. Teng, and Y.C. Wu Two new 7-dehydroaporphine alkaloids and antiplatelet action aporphines from the leaves of Annona purpurea Phytochemistry 49 7 1998 2015 2018
216. I. Jantan, J. Juriyati, and N.A. Warif Inhibitory effects of xanthones on platelet activating factor receptor binding in vitro J Ethnopharmacol 75 2 2001 287 290
217. F.M. AbuaZidan, and J.A. Windsor Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials Eur J Surg 168 4 2002 215 219
218. P. Leveau, X. Wang, Z. Sun, A. Brjesson, E. Andersson, and R. Andersson Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant Biochem Pharmacol 69 9 2005 1325 1331
219. J.L. Vincent, H. Spapen, J. Bakker, N.R. Webster, and L. Curtis Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis Crit Care Med 28 3 2000 638 642
220. G. Schifitto, N. Sacktor, K. Marder, M.P. McDermott, J.C. McArthur, and K. Kieburtz Randomized trial of the platelet-activating factor antagonist lexipafant in HIV associated cognitive impairment Neurology 53 2 1999 391
221. H.M. Brecht, W.S. Adamus, H.O. Heuer, F.W. Birke, and E.R. Kempe Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man Arzneimittelforschung 41 1 1991 51 59
222. M. Kato, T. Kurose, T. Oda, and S. Miyaji The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis J Ocul Pharmacol Ther 19 4 2003 315 324
223. D.P. Spence, S.L. Johnston, P.M. Calverley, P. Dhillon, C. Higgins, and E. Ramhamadany The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma Am J Respir Crit Care Med 149 5 1994 1142 1148
224. C.D. Gardner, J.L. Zehnder, A.J. Rigby, J.R. Nicholus, and J.W. Farquhar Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial Blood Coagul Fibrinolysis 18 8 2007 787 793
225. C.D. Gardner, R.E. Taylor-Piliae, A. Kiazand, J. Nicholus, A.J. Rigby, and J.W. Farquhar Effect of Ginkgo biloba (EGb 761) on treadmill walking time among adults with peripheral artery disease: a randomized clinical trial J Cardiopulm Rehabil Prev 28 4 2008 258 265
226. H. Lv, G. Wang, X. Wu, L. Xie, C. Huang, and H. Li Transport characteristics of ginkgolide B by Caco-2 cells and examination of ginkgolide B oral absorption potential using rat in situ intestinal loop method Int J Pharm 351 1 2008 31 35
227. K. Woelkart, E. Feizlmayr, P. Dittrich, E. Beubler, F. Pinl, and A. Suter Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans Phytother Res 24 3 2010 445 450
228. W. Fang, Y. Deng, Y. Li, E. Shang, F. Fang, and P. Lv Blood brain barrier permeability and therapeutic time window of Ginkgolide B in ischemia-reperfusion injury Eur J Pharm Sci 39 1-3 2010 8 14
229. Y. Taki, K. Yokotani, S. Yamada, K. Shinozuka, Y. Kubota, and Y. Watanabe Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice Phytomedicine 19 2 2012 177 182
230. M. Lenoir, O. Muntaner, E. Pedruzzi, M. Roch-Arveiller, M. Tissot, and K. Drieu Ginkgolide B stimulates signaling events in neutrophils and primes defense activities Biochem Biophys Res Commun 335 4 2005 1149 1154
231. K.M. Maclennan, C.L. Darlington, and P.F. Smith The CNS effects of Ginkgo biloba extracts and ginkgolide B Prog Neurobiol 67 3 2002 235 257
232. C. Picado Rupatadine: pharmacological profile and its use in the treatment of allergic disorders Expert Opin Pharmacother 7 14 2006 1989 2001
233. B. Bittman Herbal medicine vs. prescription drugs: a challenging issue 1998
234. Nutritional Business Journal Herbs & Botanicals 2012
235. P. Singh, P.K. Sharma, V.K. Garg, A.K. Singh, and S.C. Mondal Hepatoprotection: role of herbal antioxidants J Pharm Biomed Sci 5 18 2011 1 6